Altamira Therapeutics Ltd. Past Service Cost Net Defined Benefit Liability Asset
Altamira Therapeutics Ltd. (CYTOF) reported Past Service Cost Net Defined Benefit Liability Asset of CHF 163.10 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset · last filed 2024-04-22
| Period end | Past Service Cost Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2023-12-31 | 163.10K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 256.34K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 162.20K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 151.62K CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 138.58K CHF 20-F · filed 2021-03-31 |
| 2018-12-31 | 90.16K CHF 20-F · filed 2020-04-16 |